Charanjit Aulakh

Array ( [id] => 7181031 [patent_doc_number] => 20050124643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase' [patent_app_type] => utility [patent_app_number] => 10/955962 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12704 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124643.pdf [firstpage_image] =>[orig_patent_app_number] => 10955962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5151981 [patent_doc_number] => 20070034863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Metal complexes' [patent_app_type] => utility [patent_app_number] => 10/573931 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9378 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20070034863.pdf [firstpage_image] =>[orig_patent_app_number] => 10573931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630579 [patent_doc_number] => 07132540 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Hindered spiro-ketal nitroxides' [patent_app_type] => utility [patent_app_number] => 10/949562 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2449 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132540.pdf [firstpage_image] =>[orig_patent_app_number] => 10949562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876487 [patent_doc_number] => 07358259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'HCV inhibitors and methods of using them' [patent_app_type] => utility [patent_app_number] => 10/951181 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13520 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358259.pdf [firstpage_image] =>[orig_patent_app_number] => 10951181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 774284 [patent_doc_number] => 07002013 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Pt complexes as phosphorescent emitters in the fabrication of organic light emitting diodes' [patent_app_type] => utility [patent_app_number] => 10/947162 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 10087 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/002/07002013.pdf [firstpage_image] =>[orig_patent_app_number] => 10947162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085902 [patent_doc_number] => 20070275953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => '2-Pyridinone Derivatives, Having Hiv Inhibiting Properties' [patent_app_type] => utility [patent_app_number] => 10/573143 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9537 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275953.pdf [firstpage_image] =>[orig_patent_app_number] => 10573143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760735 [patent_doc_number] => 20060211680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Cinnamoyl compound and use of the same' [patent_app_type] => utility [patent_app_number] => 10/572483 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71646 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211680.pdf [firstpage_image] =>[orig_patent_app_number] => 10572483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658452 [patent_doc_number] => 07105541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Naphthyl compounds, intermediates, compositions, and methods of use' [patent_app_type] => utility [patent_app_number] => 10/941777 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11928 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105541.pdf [firstpage_image] =>[orig_patent_app_number] => 10941777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255515 [patent_doc_number] => 20050075360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Spirohydantoin compounds and methods for the modulation of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 10/937878 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21634 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075360.pdf [firstpage_image] =>[orig_patent_app_number] => 10937878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117262 [patent_doc_number] => 20050070563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Spiro compounds and methods for the modulation of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 10/937880 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28638 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070563.pdf [firstpage_image] =>[orig_patent_app_number] => 10937880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4529691 [patent_doc_number] => 07923454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Opioid and opioid-like compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/936431 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12080 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923454.pdf [firstpage_image] =>[orig_patent_app_number] => 10936431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 486237 [patent_doc_number] => 07217720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => '17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/569303 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24218 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217720.pdf [firstpage_image] =>[orig_patent_app_number] => 10569303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183579 [patent_doc_number] => 20070054933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => '17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/569302 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29091 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054933.pdf [firstpage_image] =>[orig_patent_app_number] => 10569302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 571508 [patent_doc_number] => 07462720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Determination of nucleic acid using electrocatalytic intercalators' [patent_app_type] => utility [patent_app_number] => 10/933023 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8850 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462720.pdf [firstpage_image] =>[orig_patent_app_number] => 10933023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 888632 [patent_doc_number] => 07348453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-25 [patent_title] => 'Labile linkage for compound delivery to a cell' [patent_app_type] => utility [patent_app_number] => 10/929707 [patent_app_country] => US [patent_app_date] => 2004-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7642 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/348/07348453.pdf [firstpage_image] =>[orig_patent_app_number] => 10929707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813937 [patent_doc_number] => 20080194568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Pyridomorphinans, Pyridazinomorphinans and Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/718565 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17406 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194568.pdf [firstpage_image] =>[orig_patent_app_number] => 11718565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991472 [patent_doc_number] => 20050090509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Thienopyridine-phenylacetamides and their derivatives useful as new anti-angiogenic agents' [patent_app_type] => utility [patent_app_number] => 10/928674 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44694 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090509.pdf [firstpage_image] =>[orig_patent_app_number] => 10928674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779397 [patent_doc_number] => 06995265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => 'Synthesis of nicotine derivatives from nicotine' [patent_app_type] => utility [patent_app_number] => 10/925516 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5325 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995265.pdf [firstpage_image] =>[orig_patent_app_number] => 10925516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 919807 [patent_doc_number] => 07320992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => 'Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use' [patent_app_type] => utility [patent_app_number] => 10/926238 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33687 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/320/07320992.pdf [firstpage_image] =>[orig_patent_app_number] => 10926238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163107 [patent_doc_number] => 20050085425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 10/925329 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16759 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085425.pdf [firstpage_image] =>[orig_patent_app_number] => 10925329 [rel_patent_id] =>[rel_patent_doc_number] =>)